On April 30, 2024, A.I.dvisor detected a Head-and-Shoulders Top Pattern (Bearish) for Forte Biosciences (FBRX, $0.74). 1 day later, on May 01, 2024, A.I.dvisor confirmed the Bearish pattern, setting a target price of the stock. On May 15, 2024, the stock hit the target price of $0.63 – resulting in a +1 gain for traders who shorted the stock on the pattern detection date.
a clinical-stage, cancer-selective gene therapy company, which engages in the development of product candidates designed to activate a patient's immune system against their own cancer